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ABSTRACT:
Introduction – Herbal medicines play an important role globally in the health care sector and in industrialised countries they are
often considered as an alternative to mono-substance medicines. Current quality and authentication assessment methods rely
mainly on morphology and analytical phytochemistry-based methods detailed in pharmacopoeias. Herbal products however
are often highly processed with numerous ingredients, and even if these analytical methods are accurate for quality control of
specific lead or marker compounds, they are of limited suitability for the authentication of biological ingredients.
Objective – To review the benefits and limitations of DNA barcoding and metabarcoding in complementing current herbal
product authentication.
Method – Recent literature relating to DNA based authentication of medicinal plants, herbal medicines and products are
summarised to provide a basic understanding of how DNA barcoding and metabarcoding can be applied to this field.
Results –Differentmethods of quality control and authentication have varying resolution and usefulness along the value chain of
these products. DNA barcoding can be used for authenticating products based on single herbal ingredients and DNA
metabarcoding for assessment of species diversity in processed products, and bothmethods should be used in combination with
appropriate hyphenated chemical methods for quality control.
Conclusions – DNA barcoding and metabarcoding have potential in the context of quality control of both well and poorly
regulated supply systems. Standardisation of protocols for DNA barcoding and DNA sequence-based identification are necessary
before DNA-based biological methods can be implemented as routine analytical approaches and approved by the competent
authorities for use in regulated procedures. © 2017 The Authors. Phytochemical Analysis Published by John Wiley & Sons Ltd.
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Introduction
Herbal medicines play an important role in many industrialised
countries as a complement and alternative to synthetic pharma-
ceuticals. The global market for herbal products is projected to
reach US$115 billion by 2020, with Europe leading the market
(Global Industry Analyst, Inc., 2015). Their popularity is determined
by consumers’ health concerns, cultural factors, and the belief that
these are natural and thus safe (Lynch and Berry, 2007; Ipsos MORI,
2008). Medicinal plants are sources of molecules with tremendous
therapeutic potential and remarkable pools for novel drugs leads,
but evaluating their safety, pharmacological effects and efficacy re-
quires a thorough multidisciplinary scientific approach (Atanasov
et al., 2015). An increasing awareness of quality irregularities is call-
ing attention to the quality of traded mass-produced herbal prod-
ucts with direct impact on their efficacy and safety (Heinrich, 2010;
Leonti and Casu, 2013). Herbal product quality regulations vary be-
tween countries and together with a lack of standardised analytical
methods (Locatelli et al., 2014; Locatelli and Celia, 2017; Melucci
et al., 2017), complex processes for authentication and quality
monitoring along their value chains are needed (Bent, 2008;
Gertsch, 2009; Heinrich, 2015; Booker et al., 2015). Furthermore, a
challenge in herbal pharmacovigilance is the development of
novel approaches to monitor the safety of commercialised
products (Barnes, 2003; de Boer et al., 2015). In this review we dis-
cuss the benefits and limitations of the biological identification
and authentication methods, DNA barcoding and DNA
metabarcoding, and show their potential in improving the quality
control procedures of drug substances and resulting herbal prod-
ucts. The production chains of regulated or unregulated herbal
medicinal products result in different requirements at the various
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production stages. Consequently, different analytical (chemical
and biological) methods will have different roles in quality control
and authentication (Figure 1).
Regulatory status of herbal products
Herbal product regulation varies between countries. In the
European Union/European Economic Area (EU/EEA), herbal prod-
ucts fall into two main categories, herbal medicines and herbal
food supplements (botanicals), depending on their primary
intended use. The EU directive 2004/24/EC, commonly referred
to as the Traditional Herbal Medicinal Products Directive (THMPD)
establishes a simplified procedure allowing the registration of
herbal medicines as medicinal products (European Commission,
2004). The regulation applies to herbal products with a
longstanding tradition of use, that have been on the market for
at least 30 years, including 15 years in an EUmember state. No spe-
cial assays or trials are required to prove the safety of herbal med-
icines, but proof that the product is not harmful is compulsory
(European Commission, 2004; Jütte et al., 2017). Since 2004, the
EU Directive 2004/24/EC has been incorporated into national legal
systems to increase the safety of traditional herbal medicines and
to facilitate their free movement by harmonising previous national
regulatory frameworks (Vlietinck et al., 2009; Jütte et al., 2017). The
Herbal Medicinal Products Committee (HMPC) is the European
Medicines Agency’s (EMA’s) committee responsible for establish-
ing monographs on the therapeutic uses and the safety of medic-
inal products, with the pharmacovigilance of the marketed herbal
medicines being a regulatory requirement falling under the full re-
sponsibility of manufacturers and suppliers.
The EU directive 2002/46/EC defines food supplements as con-
centrated sources of nutrients or other substances with nutritional
or physiological effects, whose purpose is to supplement the nor-
mal diet (European Commission, 2002). Herbal food supplements
are governed by the legislation of each EU’s member state, and
their quality and safety need to fulfill the requirements of food leg-
islation, which are considerably less stringent than those for med-
icines. The safety and conformity with the food law requirements is
under the full responsibility of manufactures and suppliers.
As a result of these distinct legislative frameworks, the same
herbal product may coexist under different categories. For
instance, Ginkgo biloba L. is regulated as a medical product in
Germany, as a traditional herbal medical product or a food supple-
ment in the UK, and in other European countries, Russia and the
United States as a food supplement (Heinrich, 2015). Similar regu-
latory differences apply also to Hypericum perforatum, for example,
L. (St John’s wort), Echinacea sp. (coneflowers), Actaea racemosa L.
(black cohosh), Eleutherococcus senticosus (Rupr. & Maxim.) Maxim.
(Siberian ginseng).
Quality issues and analytical challenges
One of the core interests of modern pharmacognosy refers to the
identification and authentication of drug substances and to the
quality of the resulting herbal medicines (Heinrich et al., 2017).
However, the complex natural formulations, as well as the lack of
standardised operating procedures and analytical methods, com-
plicate the quality control of the herbal products. The identification
and authentication of raw plant material and final herbal products
relies on sensory and phytochemical screening techniques to
detect species-specific characters and compounds respectively
(EMA, 2006; World Health Organisation (WHO), 2011; EDQM,
2014). The European Pharmacopoeia (Ph. Eur.) is the cornerstone
of the quality control of rawmaterials and herbal products, that de-
termines analytical procedures to be applied for qualitative and
quantitative assays (EDQM, 2014; Agapouda et al., 2017). Ph. Eur.
contains monographs with recommendations of analytical proce-
dures for more than 200 primary materials (botanical drugs) and
in some cases the resulting extracts (EDQM, 2014). However,
herbal products are usually complex matrices and formulations,
resulting from manifold processing steps, that pose unique chal-
lenges to the identification and authentication of raw material
using organoleptic, morphological or microscopic features and
standard chemical analytical assessments to determine species-
specific target compounds (Khan and Smillie, 2012). The various
factors that may influence the quality of the raw material and
resulting herbal products need to be carefully taken into consider-
ation when determining the analytical method of choice for the
authentication and quality control. Factors, as for instance the sec-
ondary metabolites in plants, are prone to variability under natural
conditions from factors including age, seasonality, latitude, alti-
tude, soil conditions, and herbivory, with direct influence on the
concentration of the lead or marker compounds measured in dif-
ferent batches of raw plant material. This complex production
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Figure 1. The different stages in the production of regulated or unregulated herbal medicinal products and the role of different analytical (chemical and
biological) methods. *Methods used in quality control are also commonly used for authentication. [Colour figure can be viewed at wileyonlinelibrary.com]
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and processing will consequently be reflected in the quality of the
final herbal product (Zhang et al., 2012). Also, the more complex
herbal products contain numerous ingredients, often extracted
and processed differently, thus hampering an accurate authentica-
tion and quality control (Zhang et al., 2012; Bilia, 2014). Difficulties
in the quality assurance processes arise also from some Pharmaco-
poeias around the world allow more than one plant species as a
source for a botanical drug, or often assign similar functions in
treating certain diseases. For instance, 140 out of 551 botanical
drugs included in the 2015 edition of the Chinese Pharmacopoeia
have multiple sources (Zhao et al., 2006; Wenzig and Bauer, 2009).
Safety issues in the herbal products industry arise from the deliber-
ate use of adulterants and admixture with undeclared fillers, in or-
der to reach a certain chemical level or expected effect (Ko, 1998;
Song et al., 2000; Ernst, 2002; Yee et al., 2005; Esters et al., 2006;
Miller and Stripp, 2007; Wenzig and Bauer, 2009; Shewiyo et al.,
2012). Most likely, the fraudulent use of fillers and plant materials
of inferior quality is driven by the increasing level of consumption
of herbal products which exceed the supply capacity for some
plant species. Accidental substitutions leading to an improper
utilisation of a botanical drug also often occur in the herbal prod-
ucts industry. For instance, plant identification relying on morpho-
logical characters of the plant species, or on standard analytical
instrumental methods, may lead to misidentification in case of
phenotypic plasticity or morphologically cryptic taxa, which often
occur in some plant groups (Bickford et al., 2007). Similarly, chal-
lenges are posed by inconsistencies among vernacular names, phar-
maceutical names, scientific synonyms or incorrect use of scientific
generic names of the raw material (Wu et al., 2007; Ouarghidi
et al., 2012; Walker and Applequist, 2012; Bennett and Balick, 2014;
Saslis-Lagoudakis et al., 2015; de Boer et al., 2015). The risks from un-
reported ingredients used in the herbal products may range from
simplemisleading labelling to potentially serious adverse drug reac-
tions (Ernst, 1998; Heubl, 2010; Gilbert, 2011) or poisoning due to
toxic contaminants (Chan, 2003). In summary, along their entire
value chain, from cultivation or harvesting of the medicinal plants
to the final marketed herbal product, a plethora of factors may di-
rectly influence the quality (Zhang et al., 2012).
Developments in analytical methods
Despite major advances in the development of new analytical ap-
proaches, there is still a significant gap in quality control strategies
that are applied to herbal products. For industrial analysis, empha-
sis has been placed on using single quick and thus cost-effective
techniques (i.e. TLC, HPTLC or HPLC) for primary qualitative analy-
sis, or alternatively using hyphenated methods (i.e. HPLC-UV,
HPLC-DAD, HPLC-MS, GC-MC, or LC-NMR) to enable also the quan-
tification of the lead or marker compounds (Patel et al., 2010;
Zhang et al., 2017). Combining phytochemical and metabolomics
approaches has been suggested for quality control and authenti-
cation in herbal value chains, especially of starting materials
(Booker et al., 2012, 2014, 2016a, 2016b). Developments in DNA
sequencing have spurred the fields of DNA barcoding and DNA
metabarcoding, two approaches of increasing relevance for
authentication of herbal ingredients and products (de Boer et al.,
2015; Ichim et al., 2016; Raclariu et al., 2017a, 2017b).
DNA barcoding and metabarcoding
The use of DNA barcoding enables species-level identifications
using short standard DNA regions, known as DNA barcodes
(Hebert et al., 2003). DNA barcoding is widely applied by the scien-
tific community and industry for molecular identification to solve a
broad range of questions in taxonomy, molecular phylogenetics,
population genetics, and biogeography (Hebert and Gregory,
2005; Hajibabaei et al., 2007; Valentini et al., 2009), as well as in
trade control to prevent illegal wildlife collection and trade of flora
and fauna (Chen et al., 2008; Eurlings et al., 2013; Gathier et al.,
2013; Ghorbani et al., 2015; Janjua et al., 2016) and food product
authenticity monitoring (Wong and Hanner, 2008; Yancy et al.,
2008; Hanner et al., 2011; Cline, 2012; Di Pinto et al., 2016). In recent
years in the field of medicinal plants research on DNA barcoding
remarkable progress has been made, as reviewed by Techen
et al. (2014) and de Boer et al. (2015). Initially used as an identifica-
tion tool, DNA barcoding is now applied in the industrial quality as-
surance context to authenticate a wide range of herbal products
(de Boer et al., 2015; Parveen et al., 2016; Sgamma et al., 2017). Re-
cently, the British Pharmacopoeia included the first globally gen-
eral DNA-based identification method using Ocimum tenuiflorum
L. (Lamiaceae), with the focus on plant sampling, barcode regions,
DNA extraction, purification and amplification, and the sequences
reference database (Heinrich et al., 2017; Sgamma et al., 2017). Re-
cent investigations applied DNA barcoding to identify and authen-
ticate various marketed herbal products, reporting various degrees
of discrepancy between the expected species and the actual iden-
tified species. For instance, significant substitution was found in
98% of products of the traditional Chinese medicine (TCM),
Baitouweng, which are expected to contain Pulsatilla chinensis
(Bge.) Regel (Shi et al., 2017), 26% of single ingredient products pur-
chased from local markets in Iran (Ghorbani et al., 2017), 16% of
ginkgo herbal dietary supplements sold as dried and powdered
leaves, purchased on-line and in retail stores from the New York
area (Little, 2014), 7% of Senna and 50% of Cassiamarket products
in India (Seethapathy et al., 2014), 6% of saw palmetto herbal die-
tary supplements sold as dry, cut, gelatine capsules and compres-
sion tablets, purchased on-line and at retail stores in the New
York area (Little and Jeanson, 2013), 25% of black cohosh dietary
supplements purchased on-line and at retail stores in the New York
area (Baker et al., 2012), 50% of Korean ginseng natural health
products capsules, sold as tablets, roots, carved roots, extracts, teas
and dried and shredded products, purchased from various
commercial sources, including pharmacies and markets in Toronto
andNew York (Wallace et al., 2012), 35% of herbal tea products pur-
chased from 25 different locations in the New York area (Stoeckle
et al., 2011); and in 59% of herbal products sold as capsules, pow-
ders and tablets, purchased from the Toronto area or on-line from
distributors in the United States (Newmaster et al., 2013).
In the wake of these studies and of other recent cases exposing
discrepancies between labelling and constituents actually present
in the products, serious concerns were raised about the authentic-
ity and quality of herbal products. Sgamma et al. (2017) discusses
the feasibility and the main aspects of using DNA barcoding in
industrial quality assurance procedures. However, conventional
DNA barcoding faces practical limitations restricting the method
to the authentication of a single ingredient herbal preparations
exclusively, and only for unprocessed plant material thus before
the plant undergoes various extractions and processing steps that
usually lead to loss, degradation or mixing of DNA.
The combination of high-throughput sequencing (HTS) and
DNA barcoding, known as DNA metabarcoding, enables simulta-
neous high-throughput multi-taxa identification by using the
extracellular and/or total DNA extracted from complex samples
containing DNA of different origins (Taberlet et al., 2012; Staats
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et al., 2016). DNA metabarcoding is applicable to identification of
plant species diversity in a range of products and has been used
to investigate the level of discrepancy between the expected and
detected plant species based on the label claims of marketed
herbal products (Cheng et al., 2014; Coghlan et al., 2015; Ivanova
et al., 2016; Raclariu et al., 2017a, 2017b). For instance, Coghlan
et al. (2012) found that 15 highly processed TCMs contained species
and genera included on CITES appendices I and II. Ivanova et al.
(2016) found that 15 tested herbal supplements contained non-
listed, non-filler plant DNA. The quality of 27 tested herbal prepara-
tions was highly affected by the presence of contaminants (Cheng
et al., 2014). Out of 78 Hypericum perforatum herbal products only
68% contained the target species and detected divergence be-
tween constituent species and those listed on the label in all prod-
ucts (Raclariu et al., 2017b). Only 15% of investigated Veronica
herbal products contained the target species Veronica officinalis L.,
whereas the main known adulterant, Veronica chamaedrys L., was
detected in 62% of the products (Raclariu et al., 2017a).
All these studies report varying degrees of authentication suc-
cess. Therefore, obtaining a representative assessment of complex
herbal mixtures is influenced by many factors, including the qual-
ity and type of rawmaterial, as well as several elements of the anal-
ysis that can however be varied to optimise the results (Staats et al.,
2016). Some limitations of DNAmetabarcoding are similar to those
found in DNA barcoding. For instance, such methods may provide
positive authentication of plant ingredients based on the presence
of any amplifiable DNA, and false negatives can be expected if the
DNA has been degraded or lost during post-harvest processing or
manufacturing (de Boer et al., 2015).
In the context of the quality control of herbal products, DNA
barcoding and metabarcoding do not provide any quantitative
nor qualitative information of the active metabolites in the raw
plant material or the resulting preparation, and this narrows its ap-
plicability only to identification and authentication procedures.
However, the use to identify and discern taxa at any developmen-
tal or processed stage from which DNA can be extracted is an es-
sential advantage of DNA barcoding and metabarcoding (Hebert
et al., 2003; Hajibabaei et al., 2007). The greatest advantage of
DNA metabarcoding is its ability to identify each single species
within complex multi-ingredient and processed mixtures simulta-
neously, where the application of DNA barcoding and conven-
tional analytical methods is limited considerably. Importantly,
DNA metabarcoding data is usable for qualitative evaluation only,
to determine presence of taxa, and not for quantitative assessment
of relative species abundance based on sequence read numbers,
as many variables considerably impact the obtained sequence
read results (Staats et al., 2016). Clearly, in the context of pharma-
cognosy and pharmacovigilance, a combination of analytical
methods is unavoidable for comprehensive authentication and
quality control of raw material and resulting products (Shetti
et al., 2011; Mishra et al., 2016; Parveen et al., 2016; Heinrich et al.,
2017; Pawar et al., 2017), and DNA-based approaches offer impor-
tant novel insights.
Perspectives
Both chemical and biological methods require comparison of
detected compounds against reference standards. For chemical
methods these can be lead or marker compounds, adulterants or
more advanced computational scans of chemical databases. For
biological DNA-basedmethods there are similar advanced compu-
tational scans linked to well-curated nucleotide sequence
repositories. Chemical methods can be used in all stages for quality
control and provide insights into the presence or absence of
compounds defining a product. Biological methods based on
DNA barcoding can be used for authentication of raw biological
materials from cultivation or wild-harvest at source or before
manufacturing, but not accurately once the material is mixed with
other biological material. Biological methods based on DNA
metabarcoding can be used for authentication of finished prod-
ucts, post-marketing control and pharmacovigilance, and provide
insight into the total species diversity in a product.
Each method has its benefits and limitations, and its specific
strength when applied correctly in the herbal product value chain.
Both DNA barcoding and metabarcoding have potential in the
context of quality control of both well and poorly regulated supply
systems. DNA barcoding can be used for authenticating products
based on single herbal ingredients andDNAmetabarcoding for as-
sessment of species diversity in processed products, and both
methods should be used in combinationwith appropriate hyphen-
ated chemical methods for quality control. Standardisation of pro-
tocols for DNA barcoding and DNA sequence-based identification
are necessary before DNA-based biological methods can be imple-
mented as routine analytical approaches and approved by the
competent authorities for use in regulated procedures.
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